<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Zhengye Biotechnology Holding Limited Ordinary Shares — News on 6ix</title>
<link>https://6ix.com/company/zhengye-biotechnology-holding-limited-ordinary-shares</link>
<description>Latest news and press releases for Zhengye Biotechnology Holding Limited Ordinary Shares on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 06 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/zhengye-biotechnology-holding-limited-ordinary-shares" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835dd8d78dffbe2df124c75.webp</url>
<title>Zhengye Biotechnology Holding Limited Ordinary Shares</title>
<link>https://6ix.com/company/zhengye-biotechnology-holding-limited-ordinary-shares</link>
</image>
<item>
<title>Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure</title>
<link>https://6ix.com/company/zhengye-biotechnology-holding-limited-ordinary-shares/news/zhengye-biotechnology-holding-limited-announces-implementation-of-dual-class-share-structure</link>
<guid isPermaLink="true">https://6ix.com/company/zhengye-biotechnology-holding-limited-ordinary-shares/news/zhengye-biotechnology-holding-limited-announces-implementation-of-dual-class-share-structure</guid>
<pubDate>Mon, 06 Apr 2026 04:00:00 GMT</pubDate>
<description>Jilin, China, April 06, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine</description>
</item>
<item>
<title>Zhengye Biotechnology Holding Limited Issues 2026 Chairman’s Letter to Shareholders</title>
<link>https://6ix.com/company/zhengye-biotechnology-holding-limited-ordinary-shares/news/zhengye-biotechnology-holding-limited-issues-133000583</link>
<guid isPermaLink="true">https://6ix.com/company/zhengye-biotechnology-holding-limited-ordinary-shares/news/zhengye-biotechnology-holding-limited-issues-133000583</guid>
<pubDate>Tue, 10 Feb 2026 13:30:00 GMT</pubDate>
<description>Jilin, China, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccines in China, today announced that Mr. Zhenfa Han, Chairman of the Board of Directors of Zhengye, has issued a letter to shareholders. In the letter, Mr. Han highlights the Company’s research and operational milesto</description>
</item>
<item>
<title>Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results</title>
<link>https://6ix.com/company/zhengye-biotechnology-holding-limited-ordinary-shares/news/zhengye-biotechnology-holding-limited-announces-123000464</link>
<guid isPermaLink="true">https://6ix.com/company/zhengye-biotechnology-holding-limited-ordinary-shares/news/zhengye-biotechnology-holding-limited-announces-123000464</guid>
<pubDate>Thu, 03 Jul 2025 12:30:00 GMT</pubDate>
<description>Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccines in China, today announced its financial results for the fiscal year ended December 31, 2024.</description>
</item>
<item>
<title>Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F</title>
<link>https://6ix.com/company/zhengye-biotechnology-holding-limited-ordinary-shares/news/zhengye-biotechnology-holding-limited-receives-200500037</link>
<guid isPermaLink="true">https://6ix.com/company/zhengye-biotechnology-holding-limited-ordinary-shares/news/zhengye-biotechnology-holding-limited-receives-200500037</guid>
<pubDate>Fri, 23 May 2025 20:05:00 GMT</pubDate>
<description>Jilin, China, May 23, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccines in China, today announced that it has received a letter from the NASDAQ Stock Market, dated May 20, 2025 (the “Delinquency Letter”), notifying the Company that it is not in compliance with the requirements for co</description>
</item>
<item>
<title>Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option</title>
<link>https://6ix.com/company/zhengye-biotechnology-holding-limited-ordinary-shares/news/zhengye-biotechnology-holding-limited-announces-full-exercise-of-underwriters-over-allotment-option</link>
<guid isPermaLink="true">https://6ix.com/company/zhengye-biotechnology-holding-limited-ordinary-shares/news/zhengye-biotechnology-holding-limited-announces-full-exercise-of-underwriters-over-allotment-option</guid>
<pubDate>Tue, 14 Jan 2025 05:00:00 GMT</pubDate>
<description>Jilin, China, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine</description>
</item>
<item>
<title>Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering</title>
<link>https://6ix.com/company/zhengye-biotechnology-holding-limited-ordinary-shares/news/zhengye-biotechnology-holding-limited-announces-closing-of-initial-public-offering</link>
<guid isPermaLink="true">https://6ix.com/company/zhengye-biotechnology-holding-limited-ordinary-shares/news/zhengye-biotechnology-holding-limited-announces-closing-of-initial-public-offering</guid>
<pubDate>Wed, 08 Jan 2025 05:00:00 GMT</pubDate>
<description>Jilin, China, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine</description>
</item>
<item>
<title>Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering</title>
<link>https://6ix.com/company/zhengye-biotechnology-holding-limited-ordinary-shares/news/zhengye-biotechnology-holding-limited-announces-pricing-of-initial-public-offering</link>
<guid isPermaLink="true">https://6ix.com/company/zhengye-biotechnology-holding-limited-ordinary-shares/news/zhengye-biotechnology-holding-limited-announces-pricing-of-initial-public-offering</guid>
<pubDate>Mon, 06 Jan 2025 05:00:00 GMT</pubDate>
<description>Jilin, China, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that</description>
</item>
</channel>
</rss>